Clinical trial Recruiting at 1 site Interventional Ages 20 to 39

Reducing ultra-processed foods to improve post-meal blood sugar using continuous glucose monitors

Official title: Effects of Ultra-processed Food Reduction Intervention on Postprandial Glucose and Glycemic Variability in Korean Young Adults: Study Protocol for the ULTRA-CGM Randomized Controlled Trial

Run by Korea University · NCT07175701 · Data updated 2026-11-12

This study will try reducing ultra-processed food intake in healthy Korean adults aged 20–39 to see if it lowers post-meal blood sugar spikes and overall glucose variability using continuous glucose monitors.

Quick facts

Study typeInterventional
Ages20 Years to 39 Years
SexAll
Enrollment50 (estimated)
SponsorKorea University
Academic / other
Locations1 site (Seoul, Seoul)
StatusRecruiting
StartedOctober 11, 2025
Main results expectedAugust 31, 2026
Study endsAugust 31, 2026
Registry record updatedApril 17, 2026
Trial IDNCT07175701 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Korean adults aged 20–39 who are not pregnant, do not have diabetes, get at least 25% of daily energy from ultra-processed foods, can wear a CGM, and can attend follow-up visits.

Probably not a fit

People with diagnosed diabetes, those planning special or restrictive diets, pregnant individuals, or those who already consume low amounts of ultra-processed foods are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, parallel two-arm trial enrolls healthy Korean adults who consume at least 25% of their daily calories from ultra-processed foods. Participants complete a 10-day baseline period wearing a continuous glucose monitor (CGM) and logging foods and lifestyle behaviors, then are randomized to either a 40-minute one-on-one UPF-reduction dietary counseling intervention or standard national guideline counseling while maintaining total energy intake. The primary outcomes are postprandial glucose responses and measures of glycemic variability captured by CGM. The trial tests whether targeted counseling to reduce UPFs changes real-time glucose patterns in young adults without diabetes.

Why it matters

Potential benefit: If successful, the approach could show that cutting back on ultra-processed foods reduces post-meal glucose spikes and glycemic variability, supporting dietary advice to lower future diabetes risk in younger adults.

How similar studies have gone: Observational studies link high ultra-processed food intake to worse metabolic outcomes, but randomized interventions using CGM to directly test UPF reduction in young healthy adults are limited and this approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Korean adults aged 20-39 years
2. Not currently pregnant
3. No personal history of diabetes or other glucose-related conditions
4. Consume ≥25% of daily energy intake from UPFs, as assessed by an online, self-administered semi-quantitative screening food frequency questionnaire (FFQ)
5. No restriction on wearing a CGM device
6. No increased risk of bleeding
7. No prior adverse reaction to CGM devices
8. Willingness to participate in follow-up assessments

Exclusion Criteria:

1. Unable to maintain continuous follow-up during the study period (e.g., due to special plans such as traveling)
2. Planning to follow a special or restrictive diet (e.g., for weight loss) during the study period

Where it's running

  • Health Promotion Lab, College of Health Science, Korea University
    Seoul, Seoul, South Korea
    Recruiting

Study contacts

  • Principal investigator: Hannah Oh, ScD — Department of Health Policy and Management, Korea University, Seoul, Republic of Korea
  • Study coordinator: Yujin Kim, BSN
  • Email: iamyujin@korea.ac.kr
  • Phone: +82-10-8712-9763

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.